SIPAVIBART
UNII 977D2P9YYW

Substance Identification & Data

This profile provides standardized clinical and technical data for Sipavibart, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 977D2P9YYW.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2768288-97-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

977D2P9YYW

CAS Registry Number

2768288-97-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

SIPAVIBART

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C200075

National Cancer Institute reference terminology for clinical and research data.

INN ID

12778

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

MN-194

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Sipavibart. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

SIPAVIBART

Common Names & Synonyms

GAMMA1 HEAVY CHAIN HOMO SAPIENS (1-455) (VH (HOMO SAPIENS IGHV3-9*01 (94.9%) -(IGHD) -IGHJ1*01 (90.9%) L123>T (120), CDR-IMGT (8.8.18) (26-33.51-58.97-114)) (1-125) -HOMO SAPIENS IGHG1*03, G1M3, NG1M1 CH1 R120, CH3 E12, M14, IGHG1V39 CH2 F1.3, E1.2, S116, IGHG1V21 CH2 Y15.1, T16, E18 (CH1 R120 (222) (126-223), HINGE 1-15 (224-238), CH2 L1.3>F (242), L1.2>E (243), M15.1>Y (260), S16>T (262), T18>E (264), P116>S (339) (239-348), CH3 E12 (364), M14 (366) (349-453), CHS (454-455)) (126-455)), (228-214')-DISULFIDE WITH LAMBDA LIGHT CHAIN HOMO SAPIENS (1'-215') (V- LAMBDA (HOMO SAPIENS IGLV2-8*04 (94.8%) -IGLJ2*01 (100%), CDR-IMGT (9.3.9) (26-34.52-54.91-99)) (1'-109') -HOMO SAPIENS IGLC2*01 (100%) (110'-215')); DIMER (234-234'':237-237'')-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, DERIVED FROM THE CELL LINE CHO-K1, GLYCOFORM ALFA

IMMUNOGLOBULIN G1-LAMBDA, ANTI-(HOMO SAPIENS SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2) SPIKE (S) PROTEIN, RECEPTOR BINDING DOMAIN (RBD)), HOMO SAPIENS MONOCLONAL ANTIBODY

SIPAVIBART [INN]

SIPAVIBART [USAN]

SIPAVIBART [WHO-DD]

Systematic Nomenclature

IMMUNOGLOBULIN G1 (242-PHENYLALANINE,243-GLUTAMIC ACID,260-TYROSINE,262-THREONINE,264-GLUTAMIC ACID,339-SERINE), ANTI-(SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 SPIKE GLYCOPROTEIN RECEPTOR-BINDING DOMAIN) (HUMAN MONOCLONAL AZD3152 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL AZD3152 .LAMBDA.-CHAIN, DIMER

SYS